Skip to content

Commit ed05e3e

Browse files
added all refs to dataset.yml
1 parent cdbeba6 commit ed05e3e

1 file changed

Lines changed: 209 additions & 0 deletions

File tree

coderdata/dataset.yml

Lines changed: 209 additions & 0 deletions
Original file line numberDiff line numberDiff line change
@@ -297,3 +297,212 @@ datasets:
297297
- drug
298298
- drug descriptor
299299
- experiments
300+
cptac:
301+
description: Simplified and Unified Access to Cancer Proteogenomic Data
302+
references:
303+
- citation: Lindgren, C. M., Adams, D. W., Kimball, B., Boekweg, H.,
304+
Tayler, S., Pugh, S. L., & Payne, S. H. (2021).
305+
Simplified and Unified Access to Cancer Proteogenomic Data. Journal of proteome research,
306+
20(4), 1902–1910. https://doi.org/10.1021/acs.jproteome.0c00919
307+
doi: https://doi.org/10.1021/acs.jproteome.0c00919
308+
modalities:
309+
- transcriptomics
310+
- proteomics
311+
- mutations
312+
- copy_number
313+
314+
ctrpv2:
315+
description: ""
316+
references:
317+
- citation: Rees, M. G., Seashore-Ludlow, B., Cheah, J. H., Adams, D. J., Price,
318+
E. V., Gill, S., Javaid, S., Coletti, M. E., Jones, V. L., Bodycombe, N. E., Soule,
319+
C. K., Alexander, B., Li, A., Montgomery, P., Kotz, J. D., Hon, C. S., Munoz, B., Liefeld,
320+
T., Dančík, V., Haber, D. A., … Schreiber, S. L. (2016).
321+
Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nature chemical biology,
322+
12(2), 109–116. https://doi.org/10.1038/nchembio.1986
323+
doi: https://doi.org/10.1038/nchembio.1986
324+
- citation: Seashore-Ludlow, B., Rees, M. G., Cheah, J. H., Cokol, M., Price, E. V., Coletti,
325+
M. E., Jones, V., Bodycombe, N. E., Soule, C. K., Gould, J., Alexander, B., Li, A., Montgomery,
326+
P., Wawer, M. J., Kuru, N., Kotz, J. D., Hon, C. S., Munoz, B., Liefeld, T., Dančík, V., … Schreiber,
327+
S. L. (2015). Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.
328+
Cancer discovery, 5(11), 1210–1223. https://doi.org/10.1158/2159-8290.CD-15-0235
329+
doi: https://doi.org/10.1158/2159-8290.CD-15-0235
330+
- citation: Basu, A., Bodycombe, N. E., Cheah, J. H., Price, E. V., Liu, K., Schaefer, G. I.,
331+
Ebright, R. Y., Stewart, M. L., Ito, D., Wang, S., Bracha, A. L., Liefeld, T., Wawer, M.,
332+
Gilbert, J. C., Wilson, A. J., Stransky, N., Kryukov, G. V., Dancik, V., Barretina, J.,
333+
Garraway, L. A., … Schreiber, S. L. (2013).
334+
An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.
335+
Cell, 154(5), 1151–1161. https://doi.org/10.1016/j.cell.2013.08.003
336+
doi: https://doi.org/10.1016/j.cell.2013.08.003
337+
modalities:
338+
- transcriptomics
339+
- proteomics
340+
- mutations
341+
- copy_number
342+
- drugs
343+
344+
fimm:
345+
description: ""
346+
references:
347+
- citation: Mpindi, J. P., Yadav, B., Östling, P., Nevedomskaya, E., Tuomela, J.,
348+
Aittokallio, T., & Wennerberg, K. (2016). Consistency in drug response profiling. Nature, 540(7631), E5–E6.
349+
https://doi.org/10.1038/nature20171
350+
doi: https://doi.org/10.1038/nature20171
351+
- citation: Pemovska, T., Kontro, M., Yadav, B., Edgren, H., Eldfors, S., Szwajda, A., Almusa, H., Bespalov,
352+
M. M., Ellonen, P., Elonen, E., Gjertsen, B. T., Karjalainen, R., Kulesskiy, E., Lagström, S., Lehto, A., Lepistö, M.,
353+
Lundán, T., Majumder, M. M., Marti, J. M., Mattila, P., … Wennerberg, K. (2013).
354+
Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.
355+
Cancer discovery, 3(12), 1416–1429. https://doi.org/10.1158/2159-8290.CD-13-0350
356+
doi: https://doi.org/10.1158/2159-8290.CD-13-0350
357+
modalities:
358+
- transcriptomics
359+
- proteomics
360+
- mutations
361+
- copy_number
362+
- drugs
363+
364+
gcsi:
365+
description: ""
366+
references:
367+
- citation: Haverty, P. M., Lin, E., Tan, J., Yu, Y., Lam, B., Masoudi, H., Zhang, R.,
368+
Zhu, X., Ding, L., Swanson, K. D., Watanabe, C., Yang, X., Li, L., Li, M., Liang, H.,
369+
Lin, W., Lin, Y., Liu, J., Luo, J., Ma, Y., … Liang, H. (2016). Reproducible pharmacogenomic profiling of cancer cell line panels.
370+
Nature, 533(7603), 333–337. https://doi.org/10.1038/nature17987
371+
doi: https://doi.org/10.1038/nature17987
372+
- citation: Klijn, C., Durinck, S., Stawiski, E. W., Haverty, P. M., Jiang, Z., Liu, H.,
373+
Degenhardt, J., Mayba, O., Gnad, F., Liu, J., Pau, G., Reeder, J., Cao, Y., Mukhyala, K.,
374+
Selvaraj, S. K., Yu, M., Zynda, G. J., Brauer, M. J., Wu, T. D., Gentleman, R. C., … Zhang, Z. (2015).
375+
A comprehensive transcriptional portrait of human cancer cell lines. Nature biotechnology, 33(3), 306–312.
376+
https://doi.org/10.1038/nbt.3080
377+
doi: https://doi.org/10.1038/nbt.3080
378+
modalities:
379+
- transcriptomics
380+
- proteomics
381+
- mutations
382+
- copy_number
383+
- drugs
384+
385+
gdscv1:
386+
description: ""
387+
references:
388+
- citation: Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau,
389+
K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., Liu, Q., Iorio, F., Surdez, D.,
390+
Chen, L., Milano, R. J., Bignell, G. R., Tamura, K., Gaasenbeek, M., Mukherjee, S.,
391+
Berger, M. F., … McDermott, U. (2012). Systematic identification of genomic markers of drug sensitivity in cancer cells.
392+
Nature, 483(7391), 570–575. https://doi.org/10.1038/nature11005
393+
doi: https://doi.org/10.1038/nature11005
394+
- citation: Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N.,
395+
Gonçalves, E., Barthorpe, S., Lightfoot, H., Cokelaer, T., Greninger, P., van Dyk, E., Chang, H., de Silva,
396+
H., Heyn, H., Deng, X., Egan, R. K., Liu, Q., Mironenko, T., … Garnett, M. J. (2016).
397+
A Landscape of Pharmacogenomic Interactions in Cancer. Cell, 166(3), 740–754. https://doi.org/10.1016/j.cell.2016.06.017
398+
doi: https://doi.org/10.1016/j.cell.2016.06.017
399+
- citation: Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D.,
400+
Smith, J. A., Thompson, I. R., Ramaswamy, S., Futreal, P. A., Haber, D. A., Stratton, M. R., Benes, C., McDermott, U.,
401+
& Garnett, M. J. (2013). Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.
402+
Nucleic acids research, 41(Database issue), D955–D961. https://doi.org/10.1093/nar/gks1111
403+
doi: https://doi.org/10.1093/nar/gks1111
404+
modalities:
405+
- transcriptomics
406+
- proteomics
407+
- mutations
408+
- copy_number
409+
- drugs
410+
411+
gdscv2:
412+
description: ""
413+
references:
414+
- citation: Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau,
415+
K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., Liu, Q., Iorio, F., Surdez, D.,
416+
Chen, L., Milano, R. J., Bignell, G. R., Tamura, K., Gaasenbeek, M., Mukherjee, S.,
417+
Berger, M. F., … McDermott, U. (2012). Systematic identification of genomic markers of drug sensitivity in cancer cells.
418+
Nature, 483(7391), 570–575. https://doi.org/10.1038/nature11005
419+
doi: https://doi.org/10.1038/nature11005
420+
- citation: Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N.,
421+
Gonçalves, E., Barthorpe, S., Lightfoot, H., Cokelaer, T., Greninger, P., van Dyk, E., Chang, H., de Silva,
422+
H., Heyn, H., Deng, X., Egan, R. K., Liu, Q., Mironenko, T., … Garnett, M. J. (2016).
423+
A Landscape of Pharmacogenomic Interactions in Cancer. Cell, 166(3), 740–754. https://doi.org/10.1016/j.cell.2016.06.017
424+
doi: https://doi.org/10.1016/j.cell.2016.06.017
425+
- citation: Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D.,
426+
Smith, J. A., Thompson, I. R., Ramaswamy, S., Futreal, P. A., Haber, D. A., Stratton, M. R., Benes, C., McDermott, U.,
427+
& Garnett, M. J. (2013). Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.
428+
Nucleic acids research, 41(Database issue), D955–D961. https://doi.org/10.1093/nar/gks1111
429+
doi: https://doi.org/10.1093/nar/gks1111
430+
modalities:
431+
- transcriptomics
432+
- proteomics
433+
- mutations
434+
- copy_number
435+
- drugs
436+
437+
pancpdo:
438+
description: ""
439+
references:
440+
- citation: Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D.,
441+
Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., Miyabayashi, K., Young, C. M.,
442+
Patel, H., Shah, M., Sanghvi, R., Goetz, A. B., Lowder, C. Y., Martello, L., Driehuis, E., LeComte, N.,
443+
… Shen, M. (2018). Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.
444+
Cancer discovery, 8(9), 1112–1129. https://doi.org/10.1158/2159-8290.CD-18-0349
445+
doi: https://doi.org/10.1158/2159-8290.CD-18-0349
446+
modalities:
447+
- transcriptomics
448+
- mutations
449+
- copy_number
450+
- drugs
451+
452+
sarcpdo:
453+
description: ""
454+
references:
455+
- citation: Al Shihabi, A., Tebon, P. J., Nguyen, H. T. L., Chantharasamee, J., Sartini, S.,
456+
Davarifar, A., Jensen, A. Y., Diaz-Infante, M., Cox, H., Gonzalez, A. E., Norris, S., Sperry, J.,
457+
Nakashima, J., Tavanaie, N., Winata, H., Fitz-Gibbon, S. T., Yamaguchi, T. N., Jeong, J. H.,
458+
Dry, S., Singh, A. S., … Soragni, A. (2024). The landscape of drug sensitivity and resistance in sarcoma.
459+
Cell Stem Cell, 31(10), 1524–1542.e4. https://doi.org/10.1016/j.stem.2024.08.010
460+
doi: https://doi.org/10.1016/j.stem.2024.08.010
461+
modalities:
462+
- transcriptomics
463+
- mutations
464+
- drugs
465+
466+
crcpdo:
467+
description: ""
468+
references:
469+
- citation: van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W.,
470+
van Gorp, J., Taylor-Weiner, A., Kester, L., McLaren-Douglas, A., Blokker, J., Jaksani, S., Bartfeld, S., Volckman,
471+
R., van Sluis, P., Li, V. S., Seepo, S., Sekhar Pedamallu, C., Cibulskis, K., … Clevers, H. (2015).
472+
Prospective derivation of a living organoid biobank of colorectal cancer patients.
473+
Cell, 161(4), 933–945. https://doi.org/10.1016/j.cell.2015.03.053
474+
doi: https://doi.org/10.1016/j.cell.2015.03.053
475+
modalities:
476+
- transcriptomics
477+
- mutations
478+
- copy_number
479+
- drugs
480+
481+
liverpdo:
482+
description: ""
483+
references:
484+
- citation: Ji, S., Feng, L., Fu, Z., Wu, G., Wu, Y., Lin, Y., Lu, D., Song, Y., Cui, P., Yang, Z.,
485+
Sang, C., Song, G., Cai, S., Li, Y., Lin, H., Zhang, S., Wang, X., Qiu, S., Zhang, X., Hua, G., … Gao, Q. (2023).
486+
Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology. Science translational medicine,
487+
15(706), eadg3358. https://doi.org/10.1126/scitranslmed.adg3358
488+
doi: https://doi.org/10.1126/scitranslmed.adg3358
489+
modalities:
490+
- transcriptomics
491+
- mutations
492+
- copy_number
493+
- drugs
494+
495+
novartispdx:
496+
description: ""
497+
references:
498+
- citation: Gao, H., Korn, J. M., Ferretti, S., Monahan, J. E., Wang, Y., Singh, M., Zhang, C., Schnell, C.,
499+
Yang, G., Zhang, Y., Balbin, O. A., Barbe, S., Cai, H., Casey, F., Chatterjee, S., Chiang, D. Y., Chuai, S.,
500+
Cogan, S. M., Collins, S. D., Dammassa, E., … Sellers, W. R. (2015).
501+
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
502+
Nature medicine, 21(11), 1318–1325. https://doi.org/10.1038/nm.3954
503+
doi: https://doi.org/10.1038/nm.3954
504+
modalities:
505+
- transcriptomics
506+
- mutations
507+
- copy_number
508+
- drugs

0 commit comments

Comments
 (0)